PharmaBoardroom

Interview: Prof. Jürg Utzinger – Director, Swiss Tropical…

Professor Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) emphasizes the importance of partnerships and sharing…

Interview: Ludo Ooms – Managing Director…

Janssen Switzerland’s Ludo Ooms highlights the strengths of the Swiss healthcare and life sciences sector including the efficiency of the…

Italy Pharma Map

The following map shows the importance of the pharmaceutical industry to the highly regionalised Italian industry. Lombardy in the North of Italy…

Big Data in Czech Pharma: At the Vanguard of a Revolution

Novartis Czech Republic's Heidrun Irschik explains the potentially game-changing ramifications of Big Data on the Czech pharmaceutical and healthcare…

Italian Pharma SMEs: Family Knows Best!

Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies must be amenable to outside…

Number of Clinical Trials in Italy

The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

Interview: Gabriel O’Shea – National Commissioner, Seguro…

Gabriel O’Shea, National Commissioner of Seguro Popular, on how the institute generates more efficient and transparent resource allocation across…

Italy Pharma Industry Factsheet

The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export…

Interview: Professor Dr. Susan M. Gasser – Director,…

Professor Dr. Susan M. Gasser of the Friedrich Miescher Institute for Biomedical Research describes FMI’s fundamental connection between academia…

Interview: Elie Lobel – CEO, Orange Healthcare, France

Orange Healthcare CEO Elie Lobel discusses the importance of digitalization to the healthcare industry, major challenges, and the tremendous work that…

Interview: Pamela Alexa – Country Manager, Pfizer…

Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active…

Swiss Pharma’s New Entrepreneurial Mind-Set

Switzerland’s pharma industry is moving beyond staid conservatism and embracing risk in order to compete internationally and foster a new culture of…

Tagged with IT